Diagnosis and treatment of autoimmune haemolytic anaemias in adults: A clinical review

Wiener Klinische Wochenschrift

Volumn 120, Issue 5-6, 2008, Pages 136-151

  Valent, Peter ^a   Lechner, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmune haemolytic anaemia; CLL; Diagnosis; Rituximab; Treatment

Indexed keywords

ALEMTUZUMAB; ALPHA INTERFERON; AZATHIOPRINE; BILIRUBIN; BLOCKING ANTIBODY; CHLORAMBUCIL; CISPLATIN; CLADRIBINE; COLD AGGLUTININ; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; DANAZOL; DOXORUBICIN; FLUDARABINE; GLUCOCORTICOID; HAPTOGLOBIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; LACTATE DEHYDROGENASE; MITOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NUCLEOSIDE DERIVATIVE; PENTOSTATIN; PREDNISONE; RITUXIMAB; STEROID; UNINDEXED DRUG; VINCRISTINE;

ADULT DISEASE; ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLLAGEN DISEASE; COOMBS POSITIVE HEMOLYTIC ANEMIA; COOMBS TEST; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; HEMOLYSIS; HODGKIN DISEASE; HUMAN; HYPERBILIRUBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LOW DRUG DOSE; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PROTEIN BLOOD LEVEL; REMISSION; RETICULOCYTOSIS; REVIEW; SICKLE CELL ANEMIA; SOLID TUMOR; SPLENECTOMY; SYMPTOMATOLOGY; THALASSEMIA; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ADULT; ALGORITHMS; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; IMMUNIZATION, PASSIVE; PROGNOSIS; RISK FACTORS; SPLENECTOMY;

EID: 41749086231     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-008-0945-1     Document Type: Review

References (181)

1. Serrano J (1992) Autoimmune hemolytic anemia. Review of 200 cases studied in a period of 20 years (1970-1989). Sangre (Barc) 37: 265-274
2. Franco-Garcia E, Giraldo P, Bernal M, Rubio-Felix D, Giralt M (1998) Which are the true incidence rates of primary hematological disorders acquired in our population? Sangre (Barc) 43: 356-364
3. Engelfriet CP, Overbeeke MA, von dem Borne AE (1992) Autoimmune hemolytic anemia. Semin Hematol 29: 3-12
4. Dacie SJ (1992) The haemolytic anemias, vol 3. The autoimmune haemolytic anaemias, 3rd edn. Churchill Livingstone
5. Dacie SJ (2001) The immune haemolytic anaemias: a century of exciting progress in understanding. Br J Haematol 114: 770-785
6. Gehrs BC, Friedberg RC (2002) Autoimmune hemolytic anemia. Am J Hematol 69: 258-271
7. Thomas AT (1999) Autoimmune hemolytic anemias. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (eds) Wintrobe's clinical hematology, 10th edn. Williams & Wilkins, Baltimore, pp 1233-1263
8. Gertz MA (2006) Cold agglutinin disease. Haematologica 91: 439-441
9. Gertz MA (2006) Cold hemolytic syndrome. Hematology Am Soc Hematol Educ Program 19-23
10. Hamblin TJ, Oscier DG, Young BJ (1986) Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 39: 713-716
11. Hamblin TJ (2006) Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 33: 230-239
12. King KE, Ness PM (2005) Treatment of autoimmune hemolytic anemia. Semin Hematol 42: 131-136
13. McNicholl FP (2000) Clinical syndromes associated with cold agglutinins. Transfus Sci 22: 125-133
14. Jardin F, Levesque H, Tilly H (2005) Auto-immune manifestations in Non-Hodgkin's lymphoma. Rev Med Interne 26: 557-571
15. Norton A, Roberts I (2006) Management of Evans syndrome. Br J Haematol 132: 125-137
16. Petz LD (2005) Immune hemolysis associated with transplantation. Semin Hematol 42: 145-155
17. Rosse WF, Hillmen P, Schreiber AD (2004) Immune-mediated hemolytic anemia. Hematology Am Soc Hematol Educ Program 48-62
18. Semple JW, Freedman J (2005) Autoimmune pathogenesis and autoimmune hemolytic anemia. Semin Hematol 42: 122-130
19. Crisp D, Pruzanski W (1982) B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins). Am J Med 72: 915-922
20. Lechner K, Weltermann A, Pabinger I (2006) Autoimmunthrombozytopenie (AITP) des Erwachsenen: Klinik, Diagnose und Therapie. Wien Klin Wochenschr 118: 255-264
21. Mauro FR, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, et al (2000) Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 95: 2786-2792
22. Hauswirth AW, Skrabs C, Schutzinger C, Gaiger A, Lechner K, Jäger U (2007) Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma 48: 1139-1149
23. Park KU, Song J, Kim JQ (2004) Haptoglobin genotypic distribution (including Hp0 allele) and associated serum haptoglobin concentrations in Koreans. J Clin Pathol 57: 1094-1095
24. Delanghe J, Langlois M, De Buyzere M (1998) Congenital anhaptoglobinemia versus acquired hypohaptoglobinemia. Blood 91: 3524
25. Liesveld JL, Rowe JM, Lichtman MA (1987) Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 69: 820-826
26. Elimelakh M, Dayton V, Park KS, Gruessner AC, Sutherland D, Howe RB, et al (2007) Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica 92: 1029-1036
27. Garratty G (2005) Immune hemolytic anemia associated with negative routine serology. Semin Hematol 42: 156-164
28. Borthakur G, O'Brien S, Wierda WG, Thomas DA, Cortes JE, Giles FJ, et al (2007) Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab - incidence and predictors. Br J Haematol 136: 800-805
29. D'Arena G, Laurenti L, Capalbo S, D'Arco AM, De Filippi R, Marcacci G, et al (2006) Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Am J Hematol 81: 598-602
30. Baker LR, Brain MC, Azzopardi JG, Worlledge SM (1968) Autoimmune haemolytic anaemia associated with ovarian dermoid cyst. J Clin Pathol 21: 626-630
31. Wheeler CA, Calhoun L, Blackall DP (2004) Warm reactive autoantibodies: clinical and serologic correlations. Am J Clin Pathol 122: 680-685
32. Wikman A, Axdorph U, Gryfelt G, Gustafsson L, Bjorkholm M, Lundahl J (2005) Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis. Ann Hematol 84: 150-158
33. Sokol RJ, Booker DJ, Stamps R, Sobolewski S, Haynes AP (1998) Autoimmune hemolytic anemia caused by warm-reacting IgM-class antibodies. Immunohematol 14: 53-58
34. Sokol RJ, Booker DJ, Stamps R, Booth JR, Hook V (1997) IgA red cell autoantibodies and autoimmune hemolysis. Transfusion 37: 175-181
35. Shulman IA, Branch DR, Nelson JM, Thompson JC, Saxena S, Petz LD (1985) Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA 253: 1746-1748
36. Vick DJ, Byrd JC, Beal CL, Chaffin DJ (1998) Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma. Vox Sang 74: 122-126
37. Cervera R, Asherson RA (2003) Clinical and epidemiological aspects in the antiphospholipid syndrome. Immunobiology 207: 5-11
38. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, Lopez-Soto A, et al (1994) Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 96: 3-9
39. Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA (2004) Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism. Br J Haematol 118: 1166-1169
40. Lang B, Straub RH, Weber S, Rother E, Fleck M, Peter HH (1997) Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lupus 6: 652-655
41. Rother RP, Bell L, Hillmen P, Gladwin MT (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293: 1653-1662
42. Hendrick AM (2003) Auto-immune haemolytic anaemia - a high-risk disorder for thromboembolism? Hematology 8: 53-56
43. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM (2000) Autoimmune hemolytic anemia in patients with systemic lupus erythematosus. Am J Med 108: 198-204
44. Bachmeyer C, Blum L, Chesneau AM, Richecoeur J, Testard F, Benchaa B, et al (2003) Raynaud's phenomenon with necrosis of the extremities induced by cold agglutinin disease secondary to a T-cell lymphoma. Acta Derm Venereol 83: 374-375
45. Genty I, Michel M, Hermine O, Schaeffer A, Godeau B, Rochant H (2002) Characteristics of autoimmune hemolytic anemia in adults: retrospective analysis of 83 cases. Rev Med Interne 23: 901-909
46. Duhrsen U, Augener W, Zwingers T, Brittinger G (1987) Spectrum and frequency of autoimmune derangements in Lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol 67: 235-239
47. Diehl LF, Ketchum LH (1998) Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 25: 80-97
48. Gronbaek K, D'Amore F, Schmidt K (1995) Autoimmune phenomena in non-Hodgkin's lymphoma. Leuk Lymphoma 18: 311-316
49. Jonsson V, Svendsen B, Vorstrup S, Krarup C, Schmalbruch H, Thomsen K, et al (1996) Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia. Leukemia 10: 327-332
50. Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, Catovsky D (2008) The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood 111: 1820-1826
51. Varoczy L, Gergely L, Zeher M, Szegedi G, Illes A (2002) Malignant lymphoma-associated autoimmune diseases - a descriptive epidemiological study. Rheumatol Int 22: 233-237
52. Sokol RJ, Booker DJ, Stamps R (1994) Erythrocyte autoantibodies, autoimmune haemolysis, and carcinoma. J Clin Pathol 47: 340-343
53. Orchard J, Bolam S, Myint H, Oscier DG, Hamblin TJ (1998) In patients with lymphoid tumours recovering from the autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy. Br J Haematol 102: 1112-1113
54. Byrd JC, Hertler AA, Weiss RB, Freiman J, Kweder SL, Diehl LF (1995) Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Ann Oncol 6: 300-301
55. Jourdan E, Topart D, Richard B, Jourdan J, Sotto A (2003) Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder. Leuk Lymphoma 44: 889-890
56. Eichhorst BF, Busch R, Hopfinger G, Pasold R, Hensel M, Steinbrecher C, et al (2006) German CLL Study Group. Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia. Blood 107: 885-891
57. Andriani A, Bibas M, Callea V, De Renzo A, Chiurazzi F, Marceno R, et al (1996) Autoimmune hemolytic anemia during alpha interferon treatment in nine patients with hematological diseases. Haematologica 81: 258-260
58. Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, et al (2006) Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. Haematologica 91 (S6): ECR26
59. Koksal A, Ozatli D, Haznedaroglu IC, Sunguroglu A, Karakus S, Buyukasik Y (2002) Autoimmune hemolytic anemia in Philadelphia positive chronic myeloid leukaemia with t (7;14) anomaly after 5 years of interferon alpha treatment. Haematologia (Budapest) 32: 163-167
60. Stavroyianni N, Stamatopoulos K, Viniou N, Vaiopoulos G, Yataganas X (2001) Autoimmune hemolytic anemia during alpha-interferon treatment in a patient with chronic myelogenous leukemia. Leuk Res 25: 1097-1098
61. Sacchi S, Kantarjian H, O'Brien S, Cohen PR, Pierce S, Talpaz M (1995) Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13: 2401-2407
62. Sultan SM, Begum S, Isenberg DA (2003) Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology (Oxford) 42: 230-234
63. Sohngen D, Specker C, Wehmeier A, Kiefel V, Rathmer L, Sohngen R, et al (1992) Prevalence of lupus anticoagulant, autoimmune hemolysis, thrombocytopenia and disorders of platelet function in unselected patients with SLE. Beitr Infusionsther 30: 469-473
64. Gomard-Mennesson E, Ruivard M, Koenig M, Woods A, Magy N, Ninet J, et al (2006) Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases. Lupus 15: 223-231
65. Giannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON (1997) Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Am J Gastroenterol 92: 1872-1874
66. Manosa M, Domenech E, Sanchez-Delgado J, Bernal I, Garcia-Planella E, Gassull MA (2005) Autoimmune hemolytic anemia associated with ulcerative colitis. Gastroenterol Hepatol 28: 283-284
67. Plikat K, Rogler G, Scholmerich J (2005) Coombs-positive autoimmune hemolytic anemia in Crohn's disease. Eur J Gastroenterol Hepatol 17: 661-666
68. Drobyski WR, Potluri J, Sauer D, Gottschall JL (1996) Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 17: 1093
69. Chen CY, Lu CL, Chiu CF, Chang FY, Lee SD (1997) Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: a case report and review of literature. Am J Gastroenterol 92: 1547-1549
70. Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, et al (2007) Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 39: 555-561
71. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK, et al (2004) Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 127: 67-75
72. Horn B, Viele M, Mentzer W, Mogck N, DeSantes K, Cowan M (1999) Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 24: 1009-1013
73. Chakrabarti S (2002) The place of rituximab in the treatment algorithm for post-stem cell transplant autoimmune hemolytic anemia. Haematologica 87: ELT23
74. Cwynarski K, Goulding R, Pocock C, Dazzi F, Craddock C, Kaeda J, et al (2001) Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 28: 581-586
75. Valentini RP, Imam A, Warrier I, Ellis D, Ritchey AK, Ravindranath Y, Shapiro R, Moritz ML (2006) Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia. Pediatr Transplant 10: 358-361
76. Tubman VN, Smoot L, Heeney MM (2007) Acquired immune cytopenias post-cardiac transplantation respond to rituximab. Pediatr Blood Cancer 48: 339-344
77. Retana AK, Kaplan MM, Erban JK (2007) Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature. Am J Gastroenterol 102: 197-200
78. Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT (2004) Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion 44: 67-72
79. Garratty G (2004) Autoantibodies induced by blood transfusion. Transfusion 44: 5-9
80. Hausler M, Schaade L, Hutschenreuter G, Hannig U, Kusenbach G (2000) Severe cytomegalovirus-triggered autoimmune hemolytic anemia complicating vertically acquired HIV infection. Eur J Clin Microbiol Infect Dis 19: 57-60
81. Gavazzi G, Leclercq P, Bouchard O, Bosseray A, Morand P, Micoud M (1999) Association between primary cytomegalovirus infection and severe hemolytic anemia in an immunocompetent adult. Eur J Clin Microbiol Infect Dis 18: 299-301
82. Ramos-Casals M, Garcia-Carrasco M, Lopez-Medrano F, Trejo O, Forns X, Lopez-Guillermo A, et al (2003) Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore) 82: 87-96
83. Sokol RJ, Hewitt S, Stamps BK (1982) Erythrocyte autoantibodies, autoimmune haemolysis and pregnancy. Vox Sang 43: 169-176
84. Issaragrisil S, Kruatrachue M (1983) An association of pregnancy and autoimmune haemolytic anaemia. Scand J Haematol 31: 63-68
85. Ng SC, Wong KK, Raman S, Bosco J (1990) Autoimmune haemolytic anaemia in pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 37: 83-85
86. Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, et al (2006) Primary chronic cold agglutinin disease: a population based clinical study of 86 patients. Haematologica 91: 460-466
87. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton LJ (2003) Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 102: 3759-3764
88. Michaux L, Dierlamm J, Wlodarska L, Criel A, Louwagie A, Ferrant A, et al (1998) Trisomy 3q11-q29 is recurrently observed in B-cell non-Hodgkin's lymphomas associated with cold agglutinin syndrome. Ann Hematol 76: 201-204
89. Girelli G, Adorno G, Perrone MP, Arista MC, Cardillo A, Vegna ML, et al (1988) Kidney carcinoma revealed by autoimmune hemolytic anemia. Haematologica 73: 309-311
90. Brncic N, Sever-Prebilic M, Crnic-Martinovic M, Prebilic I (2001) Severe autoimmune hemolitic anemia as a potentially fatal complication of EBV infectious mono-nucleosis. Int J Hematol 74: 352-353
91. König AL, Schabel A, Sugg U, Brand U, Roelcke D (2001) Autoimmune hemolytic anemia caused by IgG lambda-monotypic cold agglutinins of anti-Pr specificity after rubella infection. Transfusion 41: 488-492
92. Mori T, Yamada Y, Aisa Y, Uemura T, Ishida A, Ikeda Y, et al (2005) Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 36: 263-264
93. Ciaffoni S, Luzzati R, Roata C, Turrini A, Antonello O, Aprili G (1992) Presence and significance of cold agglutinins in patients with HIV infection. Haematologica 77: 233-236
94. Pirofsky B (1976) Clinical aspects of autoimmune hemolytic anemia. Semin Hematol 13: 251-265
95. Ruivard M, Tournilhac O, Montel S, Fouilhoux AC, Quainon F, Lenat A, et al (2006) Plasma exchanges do not increase red blood cell transfusion efficiency in severe autoimmune hemolytic anemia: a retrospective case-control study. J Clin Apher 21: 202-206
96. Murphy S, LoBuglio AF (1976) Drug therapy of autoimmune hemolytic anemia. Semin Hematol 13: 323-334
97. Liu H, Shao ZH, Cui ZZ, Wu YH, Qin TJ, Fu R, et al (2003) An analysis of relapse and risk factors of autoimmune hemolytic anemia and Evans syndrome. Zhonghua Xue Ye Xue Za Zhi 24: 534-537
98. Raj K, Narayanan S, Augustson B, Ho A, Mehta P, Duncan N, et al (2005) Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation. Bone Marrow Transplant 35: 299-301
99. Mueller-Eckhardt C, Salama A, Mahn I, Kiefel V, Neuzner J, Graubner M (1985) Lack of efficacy of high-dose intravenous immunoglobulin in autoimmune haemolytic anaemia: a clue to its mechanism. Scand J Haematol 34: 394-400
100. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB (1993) Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol 44: 237-242
101. Besa EC (1988) Rapid transient reversal of anemia and long-term effects of maintenance intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lymphoproliferative disorders. Am J Med 84: 691-698
102. Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME (2002) Portal vein thrombosis after splenectomy. Am J Surg 184: 631-635
103. Coon WW (1985) Splenectomy in the treatment of hemolytic anemia. Arch Surg 120: 625-628
104. Bowdler AJ (1976) The role of the spleen and splenectomy in autoimmune hemolytic disease. Semin Hematol 13: 335-348
105. Hill J, Walsh RM, McHam S, Brody F, Kalaycio M (2004) Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. Am J Hematol 75: 134-138
106. Skinner MD, Schwartz RS (1972) Immunosuppressive therapy. 1. N Engl J Med 287: 221-227
107. Meshaka G, Jacquillat C, Sultan Y (1967) The immunosuppressive agents. 3. The immunosuppressive agents in haematology. Presse Med 75: 1653-1655
108. Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA (2002) High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. Blood 100: 704-706
109. Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G, et al (2004) Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 125: 749-755
110. Shvidel L, Sigler E, Shtalrid M, Berrebi A (2006) Vincristine-loaded platelet infusion for treatment of refractory autoimmune hemolytic anemia and chronic immune thrombocytopenia: rethinking old cures. Am J Hematol 81: 423-425
111. Emilia G, Messora C, Longo G, Bertesi M (1996) Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders. Br J Haematol 93: 341-344
112. Liu H, Shao Z, Jing L (2001) The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome. Zhonghua Xue Ye Xue Za Zhi 22: 581-583
113. Cortes J, O'Brien S, Loscertales J, Kantarjian H, Giles F, Thomas D, et al (2001) Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. Cancer 92: 2016-2022
114. Zimmer-Molsberger B, Knauf W, Thiel E (1997) Mycophenolate mofetil for severe autoimmune haemolytic anemia. Lancet 350: 1003-1004
115. Howard J, Hoffbrand AV, Prentice HG, Mehta A (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. Br J Haematol 117: 712-715
116. Kotb R, Pinganaud C, Trichet C, Lambotte O, Dreyfus M, Delfraissy JF, et al (2005) Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Eur J Haematol 75: 60-64
117. Rao VK, Dugan F, Dale JK, Davis J, Tretler J, Hurley JK, et al (2005) Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol 129: 534-538
118. Ahrens N, Kingreen D, Seltsam A, Salama A (2001) Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab). Br J Haematol 114: 244-245
119. Galor A, O'Brien T (2003) Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome. Int J Hematol 78: 335-336
120. Morselli M, Luppi M, Potenza L, Tonelli S, Dini D, Leonardi G, et al (2002) Mixed warm and cold autoimmune hemolytic anemia: complete recovery after 2 courses of rituximab treatment. Blood 99: 3478-3479
121. Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, et al (2002) B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica 87: 189-195
122. Chemnitz J, Draube A, Diehl V, Wolf J (2002) Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. Am J Hematol 69: 232-233
123. Iannitto E, Ammatuna E, Marino C, Cirrincione S, Greco G, Mariani G (2002) Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody. Blood 99: 1096-1097
124. Pamuk GE, Turgut B, Demir M, Tezcan F, Vural O (2006) The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. Am J Hematol 81: 631-633
125. Paydas S, Yavuz S, Disel U, Sahin B, Ergin M (2003) Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase. Leuk Lymphoma 44: 2165-2166
126. Shvidel L, Shtalrid M, Berrebi A (2004) Intractable autoimmune hemolytic anemia in B cell chronic lymphocytic leukaemia resolved by Rituximab. Leuk Lymphoma 45: 1493-1494
127. Seipelt G, Bohme A, Koschmieder S, Hoelzer D (2001) Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome. Ann Hematol 80: 170-173
128. Trape G, Fianchi L, Lai M, Laurenti L, Piscitelli R, Leone G, et al (2003) Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders. Haematologica 88: 223-225
129. Zaja F, Russo D, Fuga G, Michelutti T, Sperotto A, Fanin R, et al (2001) Rituximab in a case of cold agglutinin disease. Br J Haematol 115: 232-233
130. Hofer S, Hunziker S, Dirnhofer S, Ludwig C (2003) Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma. Br J Haematol 122: 690-691
131. Quinn JP, Gilligan OM, Horgan M (2004) Evan's syndrome complicating multicentric Castleman's disease - dramatic response to rituximab. Eur J Haematol 73: 384-385
132. Ramanathan S, Koutts J, Hertzberg MS (2005) Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab. Am J Hematol 78: 123-126
133. Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B (2002) Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Br J Haematol 116: 465-467
134. Abdel-Raheem MM, Potti A, Kobrinsky N (2001) Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody. Ann Hematol 80: 543-545
135. Akyildiz M, Karasu Z, Cagirgan S, Kilic M, Tokat Y (2004) Rituximab therapy for life-threatening immune haemolytic anemia in a liver tranplant recipient: a case report. Transplant Proc 36: 1492-1493
136. Qazilbash MH, Qu Z, Hosing C, Couriel D, Donato M, Giralt S, et al (2005) Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia. Am J Hematol 80: 43-45
137. Raj A, Bertolone S, Cheerva A (2004) Successful treatment of refractory autoimmune hemolytic anemia with monthly rituximab following nonmyeloablative stem cell transplantation for sickle cell disease. J Pediatr Hematol Oncol 26: 312-314
138. Narat S, Gandla J, Hoffbrand AV, Hughes RG, Mehta AB (2005) Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica 90: 1273-1274
139. Shanafelt TD, Madueme HL, Wolf RC, Tefferi A (2003) Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc 78: 1340-1346
140. Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, et al (2003) Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 101: 3857-3861
141. Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, et al (2002) Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia 16: 2092-2095
142. Willis F, Marsh JC, Bevan DH, Killick SB, Lucas G, Griffiths R, et al (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114: 891-898
143. Cheung WW, Hwang GY, Tse E, Kwong YL (2006) Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab. Haematologica 91 (S5): ECR13
144. Karlsson C, Hansson L, Celsing F, Lundin J (2007) Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia 21: 511-514
145. Lundin J, Karlsson C, Celsing F (2006) Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia. Med Oncol 23: 137-139
146. Rodon P, Breton P, Courouble G (2003) Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H. Eur J Haematol 70: 319-321
147. Schutzinger C, Gaiger A, Thalhammer R, Vesely M, Fritsche-Polanz R, Schwarzinger I, et al (2005) Remission of pure red cell aplasia in T-cell receptor gamma-delta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab. Leukemia 19: 2005-2008
148. Kunitomi A, Konaka Y, Yagita M, Nishimoto N, Kishimoto T, Takatsuki K (2004) Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia. Int J Hematol 80: 246-249
149. Bastion Y, Coiffier B, Dumontet C, Espinouse D, Bryon PA (1992) Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann Oncol 3: 171-172
150. Jindra P, Koza V, Fiser J, Vozobulova V, Svojgrova M (1999) Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications. Bone Marrow Transplant 24: 215-217
151. Tosti S, Caruso R, D'Adamo F, Picardi A, Ali Ege M, Girelli G, et al (1992) Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Ann Hematol 65: 238-239
152. Krykowski E, Warzocha K, Robak T (1995) 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia. Arch Immunol Ther Exp (Warsz) 43: 317-321
153. Robak T, Blasinska-Morawiec M, Krykowski E, Hellmann A, Konopka L (1997) Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine). Eur J Haematol 58: 109-113
154. Zaucha JM, Halaburda K, Ciepluch H, Hellmann A (1994) 2-Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis. Acta Haematol Pol 25: 119-127
155. O'Connor BM, Clifford JS, Lawrence WD, Logue GL (1989) Alpha-interferon for severe cold agglutinin disease. Ann Intern Med 111: 255-256
156. Fest T, de Wazieres B, Lamy B, Maskani M, Vuitton D, Dupond JL (1994) Successful response to alpha-interferon 2b in a refractory IgM autoagglutinin-mediated hemolytic anemia. Ann Hematol 69: 147-149
157. Berentsen S, Tjonnfjord GE, Brudevold R, Gjertsen BT, Langholm R, Lokkevik E, et al (2001) Favourable response to therapy with the anti-CD20 monoclonal antibody Rituximab in primary chronic cold agglutinin disease. Br J Haematol 115: 79-83
158. Engelhardt M, Jakob A, Ruter B, Trepel M, Hirsch F, Lubbert M (2002) Severe cold hemagglutinin disease (CHD) successfully treated with rituximab. Blood 100: 1922-1923
159. Etienne A, Gayet S, Vidal F, Poullin P, Brunet C, Harle JR, et al (2004) Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment. Am J Hematol 75: 243-245
160. Mori A, Tamaru J, Sumi H, Kondo H (2002) Beneficial effects of rituximab on primary cold agglutinin disease refractory to conventional therapy. Eur J Haematol 68: 243-246
161. Petit J, Clavo M, de Sevilla AF, Gonzalez-Barca E, Domingo-Domenech E, Granena A (2003) Refractory cold agglutinin-immunohaemolytic anaemia associated to marginal zone lymphoma responding to rituximab. Hematol J 4: 450-451
162. Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, Langholm R, Knutsen H, et al (2004) Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 103: 2925-2928
163. Schollkopf C, Kjeldsen L, Bjerrum OW, Mourits-Andersen HT, Nielsen JL, Christensen BE, et al (2006) Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients. Leuk Lymphoma 47: 253-260
164. Vassou A, Alymara V, Chaidos A, Bourantas KL (2005) Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease. Int J Hematol 81: 421-423
165. Troselj-Vukic B, Milotic I, Milotic F, Crnic-Martinovic M, Grahovac B (2007) Cytomegalovirus reactivation after low-dose steroid treatment for haemolytic anemia in a patient with primary Epstein-Barr virus infection. Wien Klin Wochenschr 119: 435-437
166. Garelli S, Mosconi L, Valbonesi M, Schieppati G, Navassa G (1980) Plasma exchange for a hemolytic crisis due to autoimmune hemolytic anemia of the IgG warm type. Blut 41: 387-391
167. McCarthy LJ, Danielson CF, Fernandez C, Skipworth E, Limiac CA, Prahlow T, Goldman J (1999) Intensive plasma exchange for severe autoimmune hemolytic anemia in a four-month-old infant. J Clin Apher 14: 190-192
168. Roy-Burman A, Glader BE (2002) Resolution of severe Donath-Landsteiner autoimmune hemolytic anemia temporally associated with institution of plasmapheresis. Crit Care Med 30: 931-934
169. von Baeyer H (2003) Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience. Ther Apher Dial 7: 127-140
170. Jones SE (1973) Autoimmune disorders and malignant lymphoma. Cancer 31: 1092-1098
171. Andrieu JM, Youinou P, Marcelli A (1981) Autoimmune haemolytic anaemia associated with Hodgkin's disease. Characteristics, prognosis and incidence (author's transl). Nouv Presse Med 10: 2951-2954
172. Pangalis GA, Moran EM, Rappaport H (1978) Blood and bone marrow findings in angioimmunoblastic lymphadenopathy. Blood 51: 71-83
173. Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B, et al (2001) Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 98: 2319-2325
174. Castellvi Suana JM, Perello Juan A, Cervantes Arnau X, Guardiola Capon J, Baliellas, et al (1994) Autoimmune hemolytic anemia, infrequent complication of ulcerative colitis. Rev Esp Enferm Dig 86: 908-911
175. Johnson S, Smith AG, Loffler H, Osby E, Juliusson G, Emmerich B, et al (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL. Lancet 347: 1432-1438
176. Boogaerts MA, Van Hoof A, Catovsky D, Kovacs M, Montillo M, Zinzani PL, et al (2001) Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. J Clin Oncol 19: 4252-4258
177. Keating MJ, O'Brien S, Albitar M, Lerner S, Plunkett W, Giles F, et al (2005) Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. Clin Oncol 23: 4079-4088
178. Tallman MS, Wollins E, Jain V, Schiller G, Shepherd J, Silver R, et al (1997) Leustatin in the treatment of patients with previously untreated chronic lymphocytic leukemia. Blood 90: 578a (abstract)
179. Robak T, Blonski JZ, Gora-Tybor J, Jamroziak K, Dwilewicz-Trojaczek J, Tomaszewska A, et al (2006) Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). Blood 108: 473-479
180. Robak T, Blonski JZ, Kasznicki M, Blasinska-Morawiec M, Krykowski E, Dmoszynska A, et al (2000) Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial. Blood 96: 2723-2729
181. Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, et al (2003) Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 125: 32-39